Our latest COVID-19 information - full Autumn programme of webinars now in place

Colin McCall

Colin McCall is a partner in the IP/IT group at Taylor Wessing. His practice focuses on the life sciences and medtech sectors. Colin advises biotech, pharmaceutical and medtech companies ranging from early stage fast growth biotechs to listed multinational pharmaceutical and medical devices companies across the full range of commercial contracts – from general commercial agreements to the more complex manufacturing, R&D collaboration and licensing/partnering agreements. Colin also has particular expertise in advising on the commercial and intellectual property aspects of technology transactions including spin-outs, start-ups, venture capital investments, M&A and IPOs.

Drafting Commercial Contracts for the Pharmaceutical Industry Training Course

Drafting Commercial Contracts for the Pharmaceutical Industry

9-11 Jun 2021

A three-day practical and interactive seminar focusing on current contract drafting, negotiating, best practice and related issues within the pharmaceutical, biotech and life sciences sectors.

Drafting Commercial Contracts for the Pharmaceutical Industry Training Course

Drafting Commercial Contracts for the Pharmaceutical Industry

24-26 Nov 2021

A three-day practical and interactive seminar focusing on current contract drafting, negotiating, best practice and related issues within the pharmaceutical, biotech and life sciences sectors.